Evidence map›Paper›PMID 36877162›Full record

ArticleCancer research2023

Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at Single-Cell Resolution.

Allison R Pine, Stefano M Cirigliano, Richa Singhania, James Nicholson, Bárbara da Silva, Christina S Leslie, Howard A Fine

Open access · greenAbstract read
In one paragraph

Article in Cancer research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Stem cell modeling of nervous system tumors.Disease models & mechanisms · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Allison R Pine *Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0003-3125-9608
Stefano M Cirigliano *Department of Neurology, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-2397-6263
Richa SinghaniaDepartment of Neurology, Weill Cornell Medicine, New York, New York.ORCID 0000-0003-4449-0980
James NicholsonDepartment of Neurology, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-4585-6924
Bárbara da SilvaDepartment of Neurology, Weill Cornell Medicine, New York, New York.ORCID 0000-0001-7829-3278
Christina S LeslieComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York.ORCID 0000-0002-4571-5910
Howard A FineDepartment of Neurology, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-6169-5702
Cornell University · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
The Center for Tumor-Immune Systems Biology at MSKCCU54CA274492 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Christina S Leslie · 2022 to 2026
$16.3M
Tumor-specific T cell state dynamics and heterogeneity in early tumorigenesisU54CA209975 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LESLIE, CHRISTINA S, RUDENSKY, ALEXANDER Y · 2016 to 2021
$11.8M
Human Brain Cancer, Rather than Brain Cancer Cells, on a PlateDP1CA228040 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI FINE, HOWARD A. · 2017 to 2021
$5.9M
Tri-Institutional PhD Program in Computational Biology & MedicineT32GM132083 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI Doron Betel, Iman Hajirasouliha · 2020 to 2026
$3.6M
NCI NIH HHS DP1 CA228040NCI NIH HHS P30 CA008748NCI NIH HHS U54 CA209975NCI NIH HHS U54 CA274492NIGMS NIH HHS T32 GM132083
6 · The paper itself

Abstract

The tumor microenvironment is necessary for recapitulating the intratumoral heterogeneity and cell state plasticity found in human primary glioblastoma (GBM). Conventional models do not accurately recapitulate the spectrum of GBM cellular states, hindering elucidation of the underlying transcriptional regulation of these states. Using our glioblastoma cerebral organoid model, we profiled the chromatin accessibility of 28,040 single cells in five patient-derived glioma stem cell lines. Integration of paired epigenomes and transcriptomes within the context of tumor-normal host cell interactions was used to probe the gene-regulatory networks underlying individual GBM cellular states in a way not readily possible in other in vitro models. These analyses identified the epigenetic underpinnings of GBM cellular states and characterized dynamic chromatin changes reminiscent of early neural development that underlie GBM cell state transitions. Despite large differences between tumors, a shared cellular compartment made up of neural progenitor-like cells and outer radial glia-like cells was observed. Together, these results shed light on the transcriptional regulation program in GBM and offer novel therapeutic targets across a broad range of genetically heterogenous GBMs. SIGNIFICANCE: Single-cell analyses elucidate the chromatin landscape and transcriptional regulation of glioblastoma cellular states and identify a radial glia-like population, providing potential targets to disrupt cell states and improve therapeutic efficacy.

Indexed as

Brain NeoplasmsGlioblastomaGliomaCell Line, TumorChromatinHumansTumor MicroenvironmentChromatin

Identifiers

PMID36877162
PMCPMC11022245
OpenAlexW4323294551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.